CSIR Central

Lupin signs an agreement with National Chemical Laboratory & DST

IR@NCL: CSIR-National Chemical Laboratory, Pune

View Archive Info
 
 
Field Value
 
Title Lupin signs an agreement with National Chemical Laboratory & DST
 
Subject Continuous purification process development
Biosimilar monoclonal antibody therapeutic
Controlled chromatography processes
Biopharmaceuticals
Biologics
Monoclonal antibodies
 
Description Pharma major Lupin has signed an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for conducting research on a continuous purification process development of a biosimilar monoclonal antibody therapeutic (mAb). Through this research collaboration, CSIR-NCL and Lupin would together work towards the development of a novel continuous purification process for manufacturing mAb therapeutics.
 
Date 2018-06-06T09:22:43Z
2018-06-06T09:22:43Z
2018-03-08
 
Type Newspaper Article
 
Identifier http://hdl.handle.net/20.500.12252/3941
 
Language en
 
Format application/pdf
 
Publisher Times of India